Improved arteriogenesis with simultaneous skeletal muscle repair in ischemic tissue by SCL+ multipotent adult progenitor cell clones from peripheral blood

Journal of Vascular Research

Volumn 41, Issue 5, 2004, Pages 422-431

  Huss, Ralf ^a   Heil, Matthias ^b   Moosmann, Sabine ^a   Ziegelhoeffer, Tibor ^b   Sagebiel, Sabine ^a   Seliger, Christian ^a   Kinston, Sarah ^c   Gottgens, Berthold ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adult stem cells; Arteriogenesis; MAP C; SCL; Tissue repair

Indexed keywords

BIOLOGICAL MARKER; CD31 ANTIGEN; COLLAGEN; PROTEIN DERIVATIVE; TRANSCRIPTION FACTOR; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD TRANSFUSION; CELL DIFFERENTIATION; CELL GROWTH; COLLATERAL CIRCULATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; HINDLIMB; HUMAN; HUMAN CELL; IN VITRO STUDY; INFUSION; MOLECULAR CLONING; MOUSE; MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; STATISTICAL SIGNIFICANCE; STEM CELL; TISSUE REPAIR;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CHRONIC DISEASE; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; ENHANCER ELEMENTS (GENETICS); FEMORAL ARTERY; ISCHEMIA; LAMININ; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MULTIPOTENT STEM CELLS; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PLASMIDS; PROTEOGLYCANS; STEM CELL TRANSPLANTATION; TRANSCRIPTION FACTORS;

EID: 9144255110     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081441     Document Type: Article

References (37)

1. Thalmeier K, Meissner P, Moosmann S, et al: Mesenchymal differentiation and organ distribution of established human stromal cell lines in NOD/SCID mice. Acta Haematol 2001;105:150-165.
2. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al: Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5:111-116.
3. Pittinger MF, Mackay AM, Beck, SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 1999;276:318-321.
4. Huss R, Hong DS, McSweeney PA, et al: Differentiation of canine marrow cells with hematopoietic characteristics from an adherent stromal cell precursor. Proc Natl Acad Sci USA 1995;92:748-752.
5. Huss R: CD34-negative stem cells as the earliest precursors of hematopoietic progeny. Exp Hematol 1998;26:1022-1023.
6. Zanjani ED, Almeida-Porada G, Livingston AG, et al: Human bone marrow CD34-negative cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 1998;26:353-358.
7. Lange C, Kaltz C, Thalmeier K, et al: Long-term hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34-, Sca-1+, Thy-1 low, c-kit+ stem cell line. J Hematotherapy Stem Cell Res 1999;8:335-342.
8. Huss R, Lange C, Weissinger EM, et al: Evidence of peripheral blood-derived, plastic adherent CD34-/low hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells 2000;18:252-260.
9. Conrad C, Göttgens B, Kinston S, et al: GATA-transcription in a small Rhodamine 123 (low) CD34(+) subpopulation of a peripheral blood-derived CD34(-) CD105(+) mesenchymal cell line. Exp Hematol 2002;30:887-895.
10. Ziegler BL, Valtieri M, Porada GA, et al: KDR receptor: A key marker defining hematopoietic stem cells. Science 1999;285:1553-1558.
11. Yano M, Iwama A, Nishio H, et al: Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells. Blood 1997;89:4317-4326.
12. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, et al: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995:376:62-66.
13. Peault B, Oberlin E, Tavian M: Emergence of hematopoietic stem cells in the human embryo. CR Biol 2002;325:1021-1026.
14. Pelosi E, Valtieri M, Coppola S, et al: Identification of the hemangioblast in postnatal life. Blood 2002;100:3203-3208.
15. Oberlin E, Tavian M, Blazsek I, et al: Blood-forming potential of vascular endothelium in the human embryo. Development 2002;129:4147-4157.
16. Begley CG, Green AR: The SCL gene: From case report to critical hematopoietic regulator. Blood 1999;93:2760-2770.
17. Göttgens B, Nastos A, Kinston S, et al: Establishing the transcriptional programme for blood: The SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors. EMBO J 2002;21:1-12.
18. Heil M, Ziegelhoeffer T, Pipp F, et al: Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol 2002;283:H2411-H2419.
19. Reyes M, Lund T, Lenvik T, et al: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98:2615-2625.
20. Grant MB, May WS, Cabalerro S, et al: Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002;8:607-612.
21. Otani A, Kinder K, Ealt K, et al: Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 2002;8:1004-1010.
22. Gering M, Rodaway AR, Gottgens B, et al: The SCL gene specifies haemangioblast development from early mesoderm. EMBO J 1998;17:4029-4045.
23. - hematopoietic and mesenchymal stem cells from various sources. Stem Cells 2000;18:1-9.
24. Huss R, Günther W, Schumm M, et al: CD34-negative hematopoietic stem cells isolated from human peripheral blood cells as ultimate precursors of hematopoietic progenitors. Infusionsther Transfusionsmed 1997;24:404-409.
25. Sanchez M, Gottgens B, Sinclair AM, et al: An SCL 3′ enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. Development 1999;126:3891-3904.
26. Choi K: The hemangioblast: A common progenitor of hematopoietic and endothelial cells. J Hematother Stem Cell Res 2002;11:91-101.
27. Scholz D, Cai WJ, Schaper W: Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis 2001;4:247-257.
28. Ziegelhoeffer T, Fernandez B, Kostin S, et al: Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 2004;94:230-238.
29. Scholz D, Ziegelhoeffer T, Helisch A, et al: Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol 2002;34:775-787.
30. Hattori K, Heissig B, Wu Y, et al: Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment. Nat Med 2002;8:841-849.
31. Pipp F, Heil M, Issbruckner K, et al: VEGF-1 - Selective VEGF homologue PlGF is arteriogenic. Evidence for a monocyte-mediated mechanism. Circ Res 2003;92:378-385.
32. Lutton A, Tjwa M, Moons L, et al: Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002;8:831-840.
33. Kamihata H, Matsubara H, Nishiue T, et al: Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vasc Biol 2002;22:1804-1810.
34. Iba O, Matsubara H, Nozawa Y, et al: Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002;106:2019-2025.
35. Huss R, Gatsios P, Graeve L, et al: Quiescence of CD34-negative hematopoietic stem cells is mediated by downregulation of Cyclin B and no STAT activation. Cytokine 2000;12:1195-1204.
36. Jiang Y, Jahagirdar B, Reinhardt RE, et al: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
37. - blood-derived human endothelial cell progenitors. Stem Cells 2001;19:304-312.